Rofecoxib administration to paediatric patients undergoing adenotonsillectomy

Paediatric Anaesthesia

Volumn 14, Issue 7, 2004, Pages 579-583

  Sheeran, P W ^a,c   Rose, J B ^b   Fazi, L M ^b   Chiavacci, R ^b   McCormick, L ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

Author keywords

Adenotonsillectomy; Children; Rofecoxib

Indexed keywords

MIDAZOLAM; MORPHINE; ROFECOXIB;

ADENOTONSILLECTOMY; AMBULATORY SURGERY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EXTUBATION; FEMALE; HOSPITAL DEPARTMENT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OUTCOMES RESEARCH; OUTPATIENT CARE; PAIN; PAIN ASSESSMENT; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM;

ADENOIDECTOMY; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMORRHAGE; HOSPITALS, PEDIATRIC; HUMANS; LACTONES; MALE; PAIN, POSTOPERATIVE; PREANESTHETIC MEDICATION; SULFONES; TONSILLECTOMY;

EID: 3042804042     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2004.01263.x     Document Type: Article

References (28)

1. Husband AD, Davis A. Pain after tonsillectomy. Clin Otolaryngol Allied Sci 1996; 21: 99-101.
2. Randall DA, Hoffer ME. Complications of tonsillectomy and adenoidectomy. Otolaryngol Head Neck Surg 1998; 118: 61-68.
3. Rømsing J, Ostergaard D, Walther-Larsen S et al. Analgesic efficacy and safety of preoperative versus postoperative ketorolac in paediatric tonsillectomy. Acta Anaesthesiol Scand 1998; 42: 770-775.
4. Sutters K, Levine J, Dibble S et al. Analgesic efficacy and safety of single-dose intramuscular ketorolac for postoperative pain management in children following tonsillectomy. Pain 1995; 61: 145-153.
5. Rusy L, Houck C, Sullivan L. A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. Anesth Analg 1995; 80: 226-229.
6. Fitz-James I, Ho J, Pang L. Effect of ketorolac on peri-operative bleeding and analgesia in pediatric tonsillectomy and adenoidectomy patients (abs). Anesth Analg 1995; 80: S581.
7. Splinter WM, Rhine EJ, Roberts DW et al. Preoperative ketorolac increases bleeding after tonsillectomy in children. Can J Anaesth 1996; 43: 560-563.
8. Gunter JB, Varughese AM, Harrington JF. Recovery and complications after tonsillectomy in children: a comparison of ketorolac and morphine. Anesth Analg 1995; 81: 1136-1141.
9. Gallagher J, Blauth J, Fornadley J. Perioperative ketorolac tromethamine and postoperative hemorrhage in cases of tonsillectomy and adenoidectomy. Laryngoscope 1995; 105: 606-609.
10. Judkins J, Dray T, Hubbell R. Intraoperative ketorolac and post-tonsillectomy bleeding. Arch Otolaryngol Head Neck Surg 1996; 122: 937-940.
11. Scott LJ, Lamb HM. Rofecoxib. Drugs 1999; 58: 499-505.
12. Hawkey C, Laine L, Simon T. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis. Arthritis Rheum 2000; 43: 370-377.
13. Langman M, Jensen D, Watson D. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999; 282: 1929-1933.
14. Chan C-C, Boyce S, Brideau C. Rofecoxib (Vioxx, MK-0966; 4-(4′Methylsulfonlyphenyl)- 3-phenyl-2-(5H)-furanone): a potent and orally active cyclooxgenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharm Exp Ther 1999; 290: 551-560.
15. Kaplan-Machlis B, Klostermeyer BS. The cyclooxgenase-2 inhibitors: safety and effectiveness. Ann Pharmacother 1999; 33: 979-988.
16. Reuben SS, Connelly NR. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 2000; 91: 1221-1225.
17. Morrison BW, Fricke J, Brown J. The optimal analgesic dose of rofecoxib: overview of six randomized controlled trials. JADA 2000; 131: 1729-1737.
18. Day R, Morrison B, Luza A. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs. ibuprofen in patients with osteoarthritis. Arch Intern Med 2000; 160: 1781-1787.
19. Bombardier C, Laine L, Reicin A. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520-1528.
20. Morrison BW, Daniels SE, Kotey P et al. Rofecoxib, a specific cyclooxgenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial. Obstret Gynecol 1999; 94: 504-508.
21. Tyler DC, Tu A, Douthit J et al. Toward validation of pain measurement tools for children: a pilot study. Pain 1993; 52: 301-309.
22. Whaley L, Wong D. Nursing Care of Infants and Children, Fourth Edition. St Louis: Mosby-Year Book, 1991: 1148.
23. Fazi L, Jantzen EC, Rose JB et al. A comparison of oral clonidine and oral midazolam as pre-anesthetic medications in the pediatric tonsillectomy patient. Anesth Analg 2001; 92: 56-61.
24. Pickering AE, Bridge HS, Nolan J et al. Double blind, placebo-controlled analgesic study of ibuprofen or rofecoxib in combination with paracetamol for tonsillectomy in children. Br J Anaesth 2002; 88: 72-77.
25. Joshi W, Connelly NR, Reuben SS et al. An evaluation of the safety and efficacy of administering rofecoxib for postoperative pain management. Anesth Analg 2003; 97: 35-38.
26. Tuomilehto H, Kokki H, Tuovinen K. Comparison of intravenous and oral ketoprofen for postoperative pain after adenoidectomy in children. Br J Anaesth 2000; 85: 224-227.
27. Nikanne E, Kokki H, Tuovinen K. Intravenous perioperative ketoprofen in small children during adenoidectomy. Br J Anaesth 1997; 78: 24-27.
28. Kokki H, Nikanne E, Tuovinen K. Intravenous intraoperative ketoprofen in small children during adenoidectomy: a dose-finding study. Br J Anaesth 1998; 81: 870-874.